MOST NOTEWORTHY: Concur Tech, TranS1 and Third Wave were today's noteworthy initiations:
- Broadpoint initiated Concur Tech (NASDAQ: CNQR) with a Strong Buy rating and $40 target. The firm believes Concur has attractive growth drivers, room for leverage, and is a market leader for innovation and growth. Wachovia is positive on TraS1's AxiaLIF procedure in lumbar fusions as it is less invasive and patients have a faster recovery period. The firm views the potential market at over $1B and started shares off with an Outperform rating.
- Shares of TranS1 (NASDAQ: TSON) were also initiated with a Buy rating and $27 target at Piper Jaffray, as they believe the company's focus on minimally invasive surgical technique for treating lower back pain provides a large market opportunity, and at Cowen with an Outperform rating, as they positive on TSON's minimally invasive platform in spinal fusions that should leaded rapid growth.
- Collins Stewart said Third Wave (NASDAQ: TWTI) is on track to file PMA submissions for 2 new screening tests for HPV by early next year and started shares with a Buy rating and $11 target.
OTHER INITIATIONS:
- Piper initiated Ardea Biosciences (NASDAQ: RDEA) with a Buy rating.
- JP Morgan initiated Lukoil (NASDAQ: LUKOY) with a Neutral rating.
- Cowen started shares of Limelight Networks (NASDAQ: LLNW) with a Neutral rating.
Serious Money: Cheapest Stocks List Shrinks from 26 to 21
Chasing Value: Hasbro Earnings Makes My Point
MEMC CEO Forgoes Bonus; Money Will Go to Retrain Workers
Reader Comments (Page 1 of 1)
11-26-2007 @ 3:06PM
Sally said...
NewsVisual article on Concur Technologies http://www.newsvisual.com/newsvisual/2007/11/experience-leve.html shows that while the company’s Executive Team is headed by two brothers, the CEO/Chairman Steve Singh and COO/President Rajeev Singh, its Board of Directors has six non-family-related members, all of whom have a wealth of business experience.